Overview
- Provides up-to-date information on topical issues concerning minimal residual disease in breast cancer patients
- Appraises the technologies available for detection and characterization of circulating and disseminated tumor cells (CTCs/DTCs)
- Discusses the relevance of CTCs and DTCs in breast cancer clinical research and practice, and the role of other blood-based biomarkers
- Includes supplementary material: sn.pub/extras
Part of the book series: Recent Results in Cancer Research (RECENTCANCER, volume 195)
Access this book
Tax calculation will be finalised at checkout
Other ways to access
About this book
Similar content being viewed by others
Keywords
Table of contents (22 chapters)
-
Introduction
-
Minimal residual disease and breast cancer metastasis
-
Technologies for circulating tumor cell (CTC) and disseminated tumor cell (DTC) detection and characterization
Editors and Affiliations
Bibliographic Information
Book Title: Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer
Editors: Michail Ignatiadis, Christos Sotiriou, Klaus Pantel
Series Title: Recent Results in Cancer Research
DOI: https://doi.org/10.1007/978-3-642-28160-0
Publisher: Springer Berlin, Heidelberg
eBook Packages: Medicine, Medicine (R0)
Copyright Information: Springer-Verlag Berlin Heidelberg 2012
Hardcover ISBN: 978-3-642-28159-4Published: 23 April 2012
Softcover ISBN: 978-3-642-44587-3Published: 09 May 2014
eBook ISBN: 978-3-642-28160-0Published: 23 April 2012
Series ISSN: 0080-0015
Series E-ISSN: 2197-6767
Edition Number: 1
Number of Pages: XIV, 254
Topics: Oncology, Gynecology, Surgical Oncology, Pathology, Cancer Research